Intranasal Dexmedetomidine VS Oral Chloral Hydrate for Rescue Sedation During Magnetic Resonance Imaging

PHASE4CompletedINTERVENTIONAL
Enrollment

158

Participants

Timeline

Start Date

September 30, 2014

Primary Completion Date

May 31, 2015

Study Completion Date

May 31, 2015

Conditions
Administration Related ReactionFailed Moderate Sedation During ProcedureChloral Hydrate Adverse Reaction
Interventions
DRUG

chloral hydrate Group

chloral hydrate 0.25 mg/kg oral solution diluted with oral syrup to 5 ml and 0.2 mL intranasal placebo (normal saline)

DRUG

low dose dexmedetomidine group

Group L received intranasal dexmedetomidine at 1mcg/kg and 5 ml oral syrup

DRUG

high dose dexmedetomidine group

Group H received intranasal dexmedetomidine at 2mcg/kg and 5 ml oral syrup

Trial Locations (2)

510000

Department of Anesthesiology of Guangzhou Women and Children's Medical Center, Guangzhou

Unknown

Guangzhou Women and Children's Medical Center, Guangzhou

All Listed Sponsors
lead

Guangzhou Women and Children's Medical Center

OTHER

NCT02239445 - Intranasal Dexmedetomidine VS Oral Chloral Hydrate for Rescue Sedation During Magnetic Resonance Imaging | Biotech Hunter | Biotech Hunter